Literature DB >> 30556656

For Debate: Paediatric T1DM: DKA is Still a Problem.

Elena Martínez1, Nancy Portillo2, Eneritz Lizarralde3, Gema Grau4, Amaia Vela5, Amaia Rodríguez4, Itxaso Rica6.   

Abstract

Although the treatment of pediatric patients with T1DM has improved ketoacidosis (DKA) remains a frequent problem.
OBJECTIVE: To estimate temporal changes in the prevalence of DKA at diagnosis of T1DM and to explore the factors associated with its occurrence.
METHODS: Paediatric patients diagnosed at Cruces University Hospital (Spain) since 1997 were included. Clinical/analytical variables at diabetes onset, Hemoglobin A1c level during the first 2 years of evolution and the presence of the honeymoon phase were studied.
RESULTS: In 209 patients the prevalence of DKA was stable over time and high (35.4%) especially in the youngest. 8.5% of patients had a severe DKA with a higher risk in older than 10. Partial remission occurred in 26% patients, less frequent in the youngest and in the subgroup with DKA at diagnosis.
CONCLUSION: The frequency of DKA although stable, remains high and is associated with a worse evolution of the disease. Copyright© of YS Medical Media ltd.

Entities:  

Keywords:  Childhood; Diabetic Ketoacidosis; Honeymoon phase; Type 1 Diabetes mellitus

Mesh:

Substances:

Year:  2018        PMID: 30556656     DOI: 10.17458/per.vol16.2018.mpr.fd.t1dmdka

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  4 in total

1.  Ketosis-prone diabetes mellitus in an obese adolescent: A case report.

Authors:  Huiwen Tan; Chun Wang; Yerong Yu
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

2.  Frequency and severity of ketoacidosis at diagnosis among childhood type 1 diabetes in Khartoum state, Sudan.

Authors:  Ahmed M Ahmed; Omar F Khabour; Samia M Ahmed; Ibrahim A Alebaid; Amna M Ibrahim
Journal:  Afr Health Sci       Date:  2020-06       Impact factor: 0.927

3.  Novel predictor of the occurrence of DKA in T1DM patients without infection: A combination of neutrophil/lymphocyte ratio and white blood cells.

Authors:  Yiping Cheng; Wenhao Yu; Yuping Zhou; Tao Zhang; Haiyan Chi; Chao Xu
Journal:  Open Life Sci       Date:  2021-12-31       Impact factor: 0.938

4.  Efficacy and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus: A systematic review and meta-analysis.

Authors:  Mao-Bing Chen; Rui-Jun Xu; Qi-Han Zheng; Xu-Wen Zheng; Hua Wang
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.